Gemfibrozil description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Gemfibrozil

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

GEMFIBROZIL DESCRIPTION


Gemfibrozil



CLINICAL PHARMACOLOGY




All Patients






*
Group:PDropPNPLLDropLNLLN=215N=494N=1283N=221N=574N=1207*



*
EventLOPIDPlaceboLOPID:Placeboat Studyat StudyHazardCl HazardStartStartRatioRatio *




DOSAGE AND ADMINISTRATION
PRECAUTIONS

INDICATIONS & USAGE



WARNINGSPRECAUTIONSCLINICAL PHARMACOLOGY




GEMFIBROZIL CONTRAINDICATIONS


  • ●      Hepatic or severe renal dysfunction, including primary biliary cirrhosis.
  • ●     Preexisting gallbladder disease (seeWARNINGS).
  • ●     Hypersensitivity to gemfibrozil.
  • ●     Combination therapy of gemfibrozil with repaglinide (seePRECAUTIONS).

WARNINGS


CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY


INDICATIONS AND USAGE

PRECAUTIONSDrug Interactions


PRECAUTIONS

1. Initial Therapy


2. Continued Therapy


3. Drug Interactions

(A) HMG-CoA Reductase Inhibitors
WARNINGS

(B) Anticoagulants


(C) Repaglinide
CONTRAINDICATIONS

(D) Bile Acid-Binding Resins


4. Carcinogenesis, Mutagenesis, Impairment of Fertility





5. Pregnancy Category C





6. Nursing Mothers


7. Hematologic Changes


8. Liver Function


9. Kidney Function


10. Pediatric Use


GEMFIBROZIL ADVERSE REACTIONS


GEMFIBROZIL (N = 2046)PLACEBO (N = 2035)Frequency in percent of subjects

WARNINGSABNORMAL LIVER FUNCTION TESTSHEMATOLOGIC CHANGESPRECAUTIONS

CAUSAL RELATIONSHIP PROBABLECAUSAL RELATIONSHIP NOT ESTABLISHEDWARNINGSDrug InteractionsPRECAUTIONSWARNINGS

DOSAGE & ADMINISTRATION

CLINICAL PHARMACOLOGY

OVERDOSAGE



HOW SUPPLIED






STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Gemfibrozil

Gemfibrozil



















Gemfibrozil

Gemfibrozil

Gemfibrozil TABLET, FILM COATED

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-296(NDC:0143-9130)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
GEMFIBROZIL GEMFIBROZIL 600 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
POLYETHYLENE GLYCOL 3000
cellulose, microcrystalline
MAGNESIUM SULFATE, UNSPECIFIED
POLYVINYL ALCOHOL
polyethylene glycol
polysorbate 80
talc
STARCH, CORN
SODIUM STARCH GLYCOLATE TYPE A POTATO
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
white 20 mm IG;225 BULLET

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-296-02 30 in 1 BLISTER PACK
2 NDC:49349-296-21 120 in 1 CANISTER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077836 2011-06-09


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.